International Ophthalmology

, Volume 28, Issue 3, pp 175–189 | Cite as

Graft failure: II. Ocular surface complications

Original Paper


Risk factors for corneal transplantation failure include both immunologic factors, such as graft rejection, corneal neovascularization, and peripheral anterior synechiae, as well as non-immunologic factors, such as ocular surface disorders (OSD) and glaucoma. This review highlights the necessity of having healthy ocular surface epithelia, tears, and eyelids. It presents different types of OSD, their underlying pathology, and their impact on native cornea and corneal grafts. In addition, a range of proposed donor and surgical factors influencing surface integrity following corneal transplant are addressed. Current medical and surgical research, both pre- and post-operative that promise to further improve the outcome of corneal grafts in the context of OSD are discussed.


Penetrating keratoplasty Ocular surface disorders Limbal stem cell deficiency 


  1. 1.
    Lemp MA (1989) The surface of the corneal graft: in vivo color specular microscopic study in the human. Tr Am Ophthalmol Soc 87:619–657Google Scholar
  2. 2.
    Rolando M, Zierhut M (2001) The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol 45(suppl 2):S203–S210PubMedCrossRefGoogle Scholar
  3. 3.
    Virenders SS, Tseng SCG (2001) New perspectives in ocular surface disorders. an integrated approach for diagnosis and management. In J Ophthalmol 49(3):153–168Google Scholar
  4. 4.
    Xu K-P, Yagi Y, Toda I, Tsubota K (1995) Tear function index: a new measure of dry eye. Arch Ophthalmol 113:84–88PubMedGoogle Scholar
  5. 5.
    Tsubota K, Satake Y, Shimazaki J (1996) Treatment of severe dry eye. Lancet 348:123PubMedCrossRefGoogle Scholar
  6. 6.
    Tsubota K, Yamada M, Urayama K (1994) Spectacle side panels and moist inserts for the treatment of dry-eye patients. Cornea 13(3):197–201PubMedCrossRefGoogle Scholar
  7. 7.
    Pflugfelder SC, Solomon A, Stern ME (2000) The diagnosis and management of dry eye: a twenty-five-year review. Cornea 19(5):644–649PubMedCrossRefGoogle Scholar
  8. 8.
    Prydal JI, Artal P, Woon H, Campbell FW (1992) Study of human precorneal tear film thickness and structure using laser interferometry. Invest Ophthalmol Vis Sci 33(6):2006–2011PubMedGoogle Scholar
  9. 9.
    Van Setten GB, Schultz GS (1994) Transforming growth factor alpha is a constant component of tear fluid. Graefes Arch Clin Exp Ophthalmol 232(9):523–526PubMedCrossRefGoogle Scholar
  10. 10.
    Van Setten GB, Viinikka L, Tervo T (1989) Epidermal growth factor is a constant component of normal human tear fluid. Graefes Arch Clin Exp Ophthalmol 227(2):184–187PubMedCrossRefGoogle Scholar
  11. 11.
    Li Q, Weng J, Mohan RR, Bennett GL, Schwall R, Wang ZF, Tabor K, Kim J, Hargrave S, Cuevas KH, Wilson SE (1996) Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea. Invest Ophthalmol Vis Sci 37(5):727–739PubMedGoogle Scholar
  12. 12.
    Kinoshita S, Kiorpes T, Friend J, Thoft RA (1982) Limbal epithelium in ocular surface wound healing. Invest Ophthalmol Vis Sci 23(1):73–80PubMedGoogle Scholar
  13. 13.
    Tseng SCG (1989) Concept and application of limbal stem cells. Eye 3(pt 2):141–157PubMedGoogle Scholar
  14. 14.
    Tsubota K, Toda I, Saito H, Shinozaki J (1995) Reconstruction of the corneal epithelium by limbal allograft transplantation for severe ocular surface disorders. Ophthalmology 102(10):1486–1496PubMedGoogle Scholar
  15. 15.
    Dua HS, Joseph A, Shanmuganathan VA, Jones RE (2003) Stem cell differentiation and the effects of deficiency. Eye 17:877–885PubMedCrossRefGoogle Scholar
  16. 16.
    Charukamnoetkanok P (2006) Corneal stem cells: bridging the knowledge gap. Semin Ophthalmol 21:1–7PubMedCrossRefGoogle Scholar
  17. 17.
    Dua HS, Azuara-Blanco A (2000) Limbal stem cells of the corneal epithelium. Surv Ophthalmol 44(5):415–425PubMedCrossRefGoogle Scholar
  18. 18.
    Alldredge OC, Krachmer JH (1981) Clinical types of corneal transplant rejection—their manifestations, frequency, preoperative correlates, and treatment. Arch Ophthalmol 99:599–604PubMedGoogle Scholar
  19. 19.
    Ma DH, Tsai RJ, Chu WK, Kao CH, Chen JK (1999) Inhibition of vascular endothelial cell morphologenesis in cultures by limbal epithelial cells. Invest Ophthalmol Vis Sci 40(8):1822–1828PubMedGoogle Scholar
  20. 20.
    Thoft RA, Friend J (1983) The X, Y, Z hypothesis of corneal epithelial maintenance. Invest Ophthalmol Vis Sci 24(10):1442–1443PubMedGoogle Scholar
  21. 21.
    Holland EJ, Shwartz GS (1996) The evolution of epithelial transplantation for severe ocular surface disease and a proposed classification system. Cornea 15(6):549–556PubMedCrossRefGoogle Scholar
  22. 22.
    Wirtschafter JD, Ketcham JM, Weinstock RJ, Tabesh T, McLoon LK (1999) Mucocutaneous junction as the major source of replacement palpebral conjunctival epithelial cells. Invest Ophthalmol Vis Sci 40(13):3138–3146PubMedGoogle Scholar
  23. 23.
    Stulting RD, Waring GO III, Bridges WZ, Cavanagh HD (1988) Effects of donor epithelium on corneal transplant survival. Ophthalmology 95(6):803–812PubMedGoogle Scholar
  24. 24.
    Feiz V, Mannis MJ, Kandavel G, McCarthy M, Izquierdo L, Eckert M, Schwab I, Torabian S, Wang J-L, Wang W (2001) Surface keratopathy after penetrating keratoplasty. Tr Am Ophthalmol Soc 99:159–170Google Scholar
  25. 25.
    Machado RAM, Mannis MJ, Mandel HA, Feiz V, Schwab IR, Wang W, Wang J-L (2002) The relationship between first postoperative day epithelial antioxidant status and eventual health of the ocular surface in penetrating keratoplasty. Cornea 21(6):574–577PubMedCrossRefGoogle Scholar
  26. 26.
    Holland EJ, Schwartz GS (1999) Epithelial stem-cell transplantation for severe ocular-surface disease. N Eng J Med 340(22):1752–1754CrossRefGoogle Scholar
  27. 27.
    Dua HS, Forrester JV (1990) The corneoscleral limbus in human corneal epithelial wound healing. Am J Ophthalmol 110(6):646–656PubMedGoogle Scholar
  28. 28.
    Ren H, Wilson G (1996) Apoptosis in the corneal epithelium. Invest Ophthalmol Vis Sci 37(6):1017–1025PubMedGoogle Scholar
  29. 29.
    Chou L, Cohen EJ, Laibson PR, Rapuano C (1994) Factors associated with epithelial defects after penetrating keratoplasty. Ophthalmic Surg 25(10):700–703PubMedGoogle Scholar
  30. 30.
    Mathers WD, Lemp MA (1991) Vortex keratopathy of the corneal graft. Cornea 10(2):93–99PubMedCrossRefGoogle Scholar
  31. 31.
    Mackman GS, Polack FM, Sydrys L (1983) Hurricane keratitis in penetrating keratoplasty. Cornea 2(1):31–34CrossRefGoogle Scholar
  32. 32.
    Meyer RF, Bobb KC (1980) Corneal epithelium in penetrating keratoplasty. Am J Ophthalmol 90:142–147PubMedGoogle Scholar
  33. 33.
    Reed DB, Mannis MJ, Hills JF (1987) Corneal epithelial healing after penetrating keratoplasty using topical healon versus balanced salt solution. Ophthalmic Surg 18(7):525–528PubMedGoogle Scholar
  34. 34.
    Nelson JD, Harvener VR, Cameron JD (1983) Cellulose acetate impressions of the ocular surface: dry eye states. Arch Ophthalmol 101(12):1869–1872PubMedGoogle Scholar
  35. 35.
    Wilson SE, Kaufman HE (1990) Graft failure after penetrating keratoplasty. Surv Ophthalmol 34(5):325–356PubMedCrossRefGoogle Scholar
  36. 36.
    Tseng SCG (1985) Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology 92(6):728–733PubMedGoogle Scholar
  37. 37.
    Schermer A, Galvin S, Sun T-T (1986) Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J Cell Biol 103(1):49–62PubMedCrossRefGoogle Scholar
  38. 38.
    Daniels JD, Dart JG, Tuft SJ, Khaw PT (2001) Corneal stem cells in review. Wound Rep Reg 9(6):483–494CrossRefGoogle Scholar
  39. 39.
    Anderson DF, Ellies P, Pires RT, Tseng SCG (2001) Amniotic membrane transplantation for partial limbal stem cell deficiency. Br J Ophthalmol 85:567–575PubMedCrossRefGoogle Scholar
  40. 40.
    Kinoshita S, Friend J, Thoft RA (1981) Sex chromatin of donor epithelium in rabbits. Invest Ophthalmol Vis Sci 21(3):434–441PubMedGoogle Scholar
  41. 41.
    Kim T, Palay DA, Lynn M (1996) Donor factors associated with epithelial defects after penetrating keratoplasty. Cornea 15(5):451–456PubMedCrossRefGoogle Scholar
  42. 42.
    Lindstrom RL, Kaufman HE, Shelnik D (1992) Optisol corneal storage medium. Am J Ophthalmol 114(3):345–356PubMedGoogle Scholar
  43. 43.
    Wagoner MD, Gonnah E-S (2005) Corneal graft survival after prolonged storage in Optisol-GS. Cornea 24:976–979PubMedCrossRefGoogle Scholar
  44. 44.
    Tsubota K, Chiba K, Shimazaki J (1991) Corneal epithelium in diabetic patients. Cornea 10(2):156–160PubMedCrossRefGoogle Scholar
  45. 45.
    Thoft RA, Friend J (1976) Corneal epithelial changes during midterm storage. Invest Ophthalmol Vis Sci 15(2):82–88Google Scholar
  46. 46.
    Mannis MJ, Zadnik K, Miller MR, Marquez M (1997) Preoperative risk factors for surface disease after penetrating keratoplasty. Cornea 16(1):7–11PubMedCrossRefGoogle Scholar
  47. 47.
    Deocampo G, Sunga RN (1963) Studies on the epithelialization of corneal grafts with methylene blue. Am J Ophthalmol 56:801–806PubMedGoogle Scholar
  48. 48.
    Khodadoust AA, Silverstein AM (1969) The survival and rejection of epithelium in experimental corneal transplants. Invest Ophthalmol 8(2):169–179PubMedGoogle Scholar
  49. 49.
    Shimazaki J, Shimmura S, Mochizuki K, Tsubota K (1999) Morphology and barrier function of the corneal epithelium after penetrating keratoplasty: association with original disease, tear function, and suture removal. Cornea 18(5):559–564PubMedCrossRefGoogle Scholar
  50. 50.
    Lemp MA, Mathers WD (1989) Corneal epithelial cell movement in humans. Eye 3(pt 4):438–445PubMedGoogle Scholar
  51. 51.
    Dana M-R, Schaumberg DA, Kowal BO, Goren MB, Rapuano CJ, Laibson PR, Cohen EJ (1995) Corneal vascularization after penetrating keratoplasty. Cornea 14(6):604–609PubMedCrossRefGoogle Scholar
  52. 52.
    Chang J-H, Gabison EE, Kato T, Azar DT (2001) Corneal neovascularization. Opin Ophthalmol 12:242–249CrossRefGoogle Scholar
  53. 53.
    Maguire MG, Stark WJ, Gottsch JD, Stulting RD, Sugar A, Fink NE, Schwartz A (1994) Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Ophthalmology 101(9):1536–1547PubMedGoogle Scholar
  54. 54.
    Tsubota K (1999) Ocular surface management in corneal transplantation: a review. Jpn J Ophthalmol 43:502–508PubMedCrossRefGoogle Scholar
  55. 55.
    Sugar A, Meyer RF, Bahn CF (1983) A randomized trial of pressure patching for epithelial defects after keratoplasty. Am J Ophthalmol 95:637–640PubMedGoogle Scholar
  56. 56.
    Lambiase A, Rama P, Aloe L, Bonni S (1999) Management of neurotrophic keratopathy. Curr Opin Ophthalmol 10:270–276PubMedCrossRefGoogle Scholar
  57. 57.
    Lemp MA (1995) Report of the national eye institute/industry workshop on clinical trials in dry eyes. CLAO J 21:222–232Google Scholar
  58. 58.
    Sommer A (1998) Xerophthalmia and vitamin A status. Prog Retin Eye Res 17:9–31PubMedCrossRefGoogle Scholar
  59. 59.
    Chan RY, Foster CS (1999) A step-wise approach to ocular surface rehabilitation in patients with ocular inflammatory disease. Int Ophthalmol Clin 39(1):83–108PubMedCrossRefGoogle Scholar
  60. 60.
    Gulati A, Dana R (2005) Keratoconjunctivitis sicca: clinical aspects. In: Foster CS, Azar DT, Dohlman CH (eds) Smolin and Thoft’s the cornea, scientific foundations and clinical practice. Lippincott Williams & Wilkins, Philadelphia, 603–627Google Scholar
  61. 61.
    Shimazaki J, Shimmura S, Fujishima H, Tsubota K (2000) Association of preoperative tear function with surgical outcome in severe Stevens-Johnson syndrome. Ophthalmology 107(8):1518–1523PubMedCrossRefGoogle Scholar
  62. 62.
    Groden LR, White W (1990) Procine collagen corneal shield treatment of persistent epithelial defects following penetrating keratoplasty. CLAO J 16(2):95–97PubMedGoogle Scholar
  63. 63.
    Schwartz GS, Holland EJ (2005) Classification and staging of ocular surface disease. In: Krachmer JH, Mannis MJ, Holland EJ (eds) Cornea, Volume 2. Elsevier, Philadelphia, 1794–1796Google Scholar
  64. 64.
    Nishida K, Kinoshita S, Ohashi Y, Kuwayama Y, Yamamoto S (1995) Ocular surface abnormalities in aniridia. Am J Ophthalmol 120(3):368–375PubMedGoogle Scholar
  65. 65.
    Wagoner MD, Al-Swailem SA, Sutphin JE, Zimmerman MB. Bacterial keratitis after penetrating keratoplasty: incidence, microbiological profile, graft survival, and visual outcome. Ophthalmology (in press)Google Scholar
  66. 66.
    Fong LP, Ormerod LD, Kenyon KR, Foster CS (1988) Microbial keratitis complicating penetrating keratoplasty. Ophthalmology 95:1269–1275PubMedGoogle Scholar
  67. 67.
    Price FW, Whitson WE, Collins KS, Marks RG (1993) Five-year corneal graft survival: a large, single-center patient cohort. Arch Ophthalmol 111:799–805PubMedGoogle Scholar
  68. 68.
    Holland EJ, Schwartz GS (2000) Changing concepts in the management of severe ocular surface disease over twenty-five years. Cornea 19(5):688–698PubMedCrossRefGoogle Scholar
  69. 69.
    Wagoner MD, Al-Swailem MD, Jastaneiah S, Kenyon KR (2007) Chemical injuries of the eye. In: Alber DM, Jacobiec FA (eds) Principles and practice of ophthalmology: clinical practice. Vol 1, ch 72, Saunders, Philadelphia Google Scholar
  70. 70.
    Di Pascuale MA, Espana EM, Liu DT-S, Kawakita T, Li W, Gao YY, Baradaran-Rafi A, Elizondo A, Raju VK, Scheffer SCG (2005) Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome. Ophthalmology 112(5):904–912PubMedCrossRefGoogle Scholar
  71. 71.
    Tseng SCG, Di Pascuale MA, Liu DT-S, Gao YY, Baradaran-Rafii A (2005) Intraoperative mitomycin C and amniotic membrane transplantation for fornix reconstruction in severe cicatricial ocular surface diseases. Ophthalmology 112(5):896–903PubMedCrossRefGoogle Scholar
  72. 72.
    Solomon A, Espana EM, Tseng SCG (2003) Amniotic membrane transplantation for reconstruction of the conjunctival fornices. Ophthalmology 110(1):93–100PubMedCrossRefGoogle Scholar
  73. 73.
    Tsubota K, Goto E, Shimmura S, Shimazaki J (1999) Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 106(10):1984–1989PubMedCrossRefGoogle Scholar
  74. 74.
    Cher I (2003) Blink-related microtrauma: when the ocular surface harms itself. Clin Experiment Ophthalmol 31:183–190PubMedCrossRefGoogle Scholar
  75. 75.
    Stern GA, Schemmer GB, Farber RD et al (1983) Effects of topical antibiotic solutions on corneal epithelial wound healing. Arch Ophthalmol 101(4):644–647PubMedGoogle Scholar
  76. 76.
    Pires RT, Chokshi A, Tseng SCG (2000) Amniotic membrane transplantation or limbal conjunctival autograft for limbal stem cell deficiency induced by 5-fluorouracil in glaucoma surgeries. Cornea 19(3):284–287PubMedCrossRefGoogle Scholar
  77. 77.
    Guidera AC, Luchs JI, Udell IJ (2001) Keratitis, ulceration and perforation associated with topical non-steroidal anti-inflammatory drugs. Ophthalmology 108(5):936–944PubMedCrossRefGoogle Scholar
  78. 78.
    Gobbels M, Spitznas M (1989) Influence of artificial teas on corneal epithelium in dry-eye syndrome. Graefes Arch Clin Exp Ophthalmol 227:139–141PubMedCrossRefGoogle Scholar
  79. 79.
    Anderson DF, Touhami A, Tseng SCG (2001) Limbal stem cell deficiency arising from systemic chemotherapy. Br J Ophthalmol 85:373–374PubMedCrossRefGoogle Scholar
  80. 80.
    Hirsh A, Alhalel A, Weiss A et al (1990) Bilateral total corneal epithelial erosion as a side effect of cytotoxic therapy. Br J Ophthalmol 74:638PubMedCrossRefGoogle Scholar
  81. 81.
    Puangsricharen V, Tseng SCG (1995) Cytologic evidence of corneal diseases with limbal stem cell deficiency. Ophthalmology 102:1476–1485Google Scholar
  82. 82.
    Shore JW, Foster CS, Westfall CT, Rubin PA (1992) Results of buccal mucosal grafting for patients with medically controlled ocular cicatricial pemphigoid. Ophthalmology 99:385–395Google Scholar
  83. 83.
    Calonge M (2001) The treatment of dry eye. Surv Ophthalmol 45:S227–S239PubMedCrossRefGoogle Scholar
  84. 84.
    Tai M-C, Cosar CB, Cohen EJ, Rapuano CJ, Laibson PR (2002) The clinical efficacy of silicone punctal plug therapy. Cornea 21(2):135–139PubMedCrossRefGoogle Scholar
  85. 85.
    Yokoi N, Komuro A, Nishida K, Kinoshita S (1997) Effectiveness of hyaluronan on corneal epithelial barrier function in dry eye. Br J Ophthalmol 81:533–536PubMedGoogle Scholar
  86. 86.
    Aragona P, Papa V, Micali A, Santocono M, Milazzo G (2002) Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol 86:181–184PubMedCrossRefGoogle Scholar
  87. 87.
    Nishida T, Nakamura M, Mishima H et al (1991) Hyaluronan stimulates corneal epithelial migration. Exp Eye Res 53:753–758PubMedCrossRefGoogle Scholar
  88. 88.
    Iester M, Orsoni GJ, Gamba G, Taffara M, Mangiafico P, Giuffrida S, Rolando M (2000) Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis. Eye 14(pt 6):892–898PubMedGoogle Scholar
  89. 89.
    Driver PJ, Lemp MA (1996) Meibomian gland dysfunction. Surv Ophthalmol 40(5):343–367PubMedCrossRefGoogle Scholar
  90. 90.
    Shimazaki J, Sakata M, Tsubota K (1995) Ocular surface changes and discomfort in patient with meibomian gland dysfunction. Arch Ophthalmol 113:1266–1270PubMedGoogle Scholar
  91. 91.
    Tseng SCG, Maumanee E, Stark WJ, Maumenee IH, Jensen AD, Green WR, Kenyon KR (1985) Topical retinoid treatment of various dry-eye disorders. Ophthalmology 92(6):717–727PubMedGoogle Scholar
  92. 92.
    Murphy PT, Sivakumaran M, Fahy G, Hutchinson RM (1996) Successful use of topical retinoic acid in severe dry eye due to chronic graft-versus-host disease. Bone Marrow Transplant 18(3):641–642PubMedGoogle Scholar
  93. 93.
    Kojima T, Ishida R, Dogru M, Goto E, Matsumoto Y, Kaido M, Tsubota K (2005) The effect of autologous serum eye drops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol 139:242–246PubMedCrossRefGoogle Scholar
  94. 94.
    Noble BA, Loh RSK, MacLennan S, Pesudovs K, Reynolds A, Bridges LR, Burr J, Stewart O, Quereshi S (2004) Comparison of autologous serum eye drops with conventional therapy in a randomized controlled crossover trial for ocular surface diseases. Br J Ophthalmol 88:647–652PubMedCrossRefGoogle Scholar
  95. 95.
    Tananuvat N, Daniell M, Sullivan LJ, Yi Q, McKelvie P, McCarty DJ, Taylor HR (2001) Controlled study of the use of autologous serum in dry eye patients. Cornea 20(8):802–806PubMedCrossRefGoogle Scholar
  96. 96.
    Matsumoto Y, Dogru M, Goto E, Ohashi Y, Kojima T, Ishida R, Tsubota K (2004) Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 111(6):1115–1120PubMedCrossRefGoogle Scholar
  97. 97.
    Poon AC, Geerling G, Dart JKG, Fraenkel GE, Daniels JT (2001) Autologous serum eye drops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol 85:1188–1197PubMedCrossRefGoogle Scholar
  98. 98.
    Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I, Shimmura S (1999) Treatment of dry eye by autologous serum application in Sjogren’s syndrome. Br J Ophthalmol 83:390–395PubMedCrossRefGoogle Scholar
  99. 99.
    Geerling G, MacLennan S, Hartwig D (2004) Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 88:1467–1474PubMedCrossRefGoogle Scholar
  100. 100.
    Goto E, Shimmura S, Shimazaki J, Tsubota K (2001) Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea 20(8):807–810PubMedCrossRefGoogle Scholar
  101. 101.
    Tsubota K, Higuchi A (2000) Serum application for the treatment of ocular surface disorders. Int Ophthalmol Clin 40(4):113–122PubMedCrossRefGoogle Scholar
  102. 102.
    Tsubota K, Satake Y, Ohyama M, Toda I, Takano Y, Ono M, Shinozaki N, Shimazaki J (1996) Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol 122:38–52PubMedGoogle Scholar
  103. 103.
    McDonnell PJ, Schanzlin DJ, Rao NA (1988) Immunoglobulin deposition in the cornea after application of autologous serum. Arch Ophthalmol 106:1423–1425PubMedGoogle Scholar
  104. 104.
    Lagnado R, King AJ, Donald F, Dua HS (2004) A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders. Br J Ophthalmol 88:464–465PubMedCrossRefGoogle Scholar
  105. 105.
    Sall K, Stevenson OD, Mundrof TK, Reis BL (2000) Cyclosporin A phase 3 study groups. Two multicenter, randomized studies of the efficacy and safety of cyclosporin ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology 107(4):631–639PubMedCrossRefGoogle Scholar
  106. 106.
    Stevenson D, Tauber J, Reis BL (2000) Cyclosporin A phase 2 study groups. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease. Ophthalmology 107(5):967–974PubMedCrossRefGoogle Scholar
  107. 107.
    Marsh P, Pflugfelder SC (1999) Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren’s syndrome. Ophthalmology 106:811–816PubMedCrossRefGoogle Scholar
  108. 108.
    Anaizi NH, Swenson CF, Dentinger PJ (1997) Stability of acetylcysteine in an extemporaneously compounded ophthalmic solution. Am J Health Syst Pharm 54:549–553PubMedGoogle Scholar
  109. 109.
    Avisar R, Robinson A, Appel I, Yassur Y, Wenberger D (2000) Diclofenac sodium 0.1% (voltaren ophtha), versus sodium chloride 5% in the treatment of filamentary keratitis. Cornea 9(2):145–147CrossRefGoogle Scholar
  110. 110.
    Tsai R J-F, Tseng SCG (1995) Effect of stromal inflammation on the outcome of limbal transplantation for corneal surface reconstruction. Cornea 14(5):439–449PubMedCrossRefGoogle Scholar
  111. 111.
    Tsubota K, Fukagawa K, Fujihara T, Shimmura S, Saito I, Saito K, Takeuchi T (1999) Regulation of human leukocyte antigen expression in human conjunctival epithelium. Invest Ophthalmol Vis Sci 40(1):28–34PubMedGoogle Scholar
  112. 112.
    Tugal-Tutkun I, Akova YA, Foster CS (1995) Penetrating keratoplasty in cicatrizing conjunctival diseases. Ophthalmology 102(4):576–585PubMedGoogle Scholar
  113. 113.
    Al-Swailem SA (2006) The role of amniotic membrane transplantation in the treatment of chemical injuries of the eye. Middle East J Ophthalmol 13(1):23–38Google Scholar
  114. 114.
    Barabino S, Rolando M, Bentivoglio G, Mingari C, Zanardi S, Bellomo R, Calabria G (2003) Role of amniotic membrane transplantation for conjunctival reconstruction in ocular-cicatricial pemphigoid. Ophthalmology 110(3):474–480PubMedCrossRefGoogle Scholar
  115. 115.
    Moyes AL, Sugar A, Mushch DC, Barnes RD (1994) Antiviral therapy after penetrating keratoplasty for herpes simplex keratitis. Arch Ophthalmol 112(5):601–607PubMedGoogle Scholar
  116. 116.
    Tambasco FP, Cohen EJ, Nguyun LH, Raphano CJ, Laibson PR (1999) Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Arch Ophthalmol 117(4):445–449PubMedGoogle Scholar
  117. 117.
    Epstein RJ, Stulting RD, Hendricks RL, Harris DM (1987) Corneal neovascularization: pathogenesis and inhibition. Cornea 6:250–257PubMedCrossRefGoogle Scholar
  118. 118.
    Pillai CT, Dua HS, Hossain P (2000) Fine needle diathermy occlusion of corneal vessels. Invest Ophthalmol Vis Sci 41:2148–2153PubMedGoogle Scholar
  119. 119.
    Cursiefen C, Wenkel H, Martus P, Langenbucher A, Nguyen NX, Seitz B, Kuchle M, Naumann GO (2001) Impact of short-term versus long-term topical steroids on corneal neovascularization after non-high-risk keratoplasty. Graefes Arch Clin Exp Ophthalmol 239(7):514–521PubMedCrossRefGoogle Scholar
  120. 120.
    Nirankari VS, Baer JC (1986) Corneal argon laser photocoagulation for neovascularization in penetrating keratoplasty. Ophthalmology 93(10):1304–1309PubMedGoogle Scholar
  121. 121.
    Hao Y, Ma DH, Hwang DG (2000) Identification of antiangiogenic and anti-inflammatory proteins in human amniotic membrane. Cornea 19:348–352PubMedCrossRefGoogle Scholar
  122. 122.
    Tseng SC, Prabhasawat P, Barton K et al (1998) Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 116:431–441PubMedGoogle Scholar
  123. 123.
    Yatoh S, Kawakami Y, Imai M, Kozawa T, Seqawa T, Suzuki H, Yamashita K, Okuda Y (1998) Effect of topically applied neutralizing antibody against vascular endothelial growth factor on corneal allograft rejection of rat. Transplantation 66(11):1519–1524PubMedCrossRefGoogle Scholar
  124. 124.
    Patel BC, Sapp NA, Collin R (1998) Standardized range of conformers and symblepharon rings. Ophthal Plast Reconstr Surg 14(2):144–145PubMedCrossRefGoogle Scholar
  125. 125.
    Fein W (1979) Repair of total and subtotal symblepharons. Ophthalmic Surg 10:44–47PubMedGoogle Scholar
  126. 126.
    Chiou AG-Y, Florakis GJ, Kazim M (1998) Management of conjunctival cicatrizing diseases and severe ocular surface dysfunction. Surv Ophthalmol 43(1):19–46PubMedCrossRefGoogle Scholar
  127. 127.
    Honavar SG, Bansal AK, Sangwan VS, Rao GN (2000) Amniotic membrane transplantation for ocular surface reconstruction in Stevens-Johnson syndrome. Ophthalmology 107:975–979PubMedCrossRefGoogle Scholar
  128. 128.
    Romero-Rangel T, Stavrou P, Cotter J, Rosenthal P, Baltatzis S, Foster CS (2000) Gas-permeable scleral contact lenses therapy in ocular surface disease. Am J Ophthalmol 130(1):25–32PubMedCrossRefGoogle Scholar
  129. 129.
    Rosenthal P, Cotter JM, Baum J (2000) Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable scleral contact lens. Am J Ophthalmol 130:33–41PubMedCrossRefGoogle Scholar
  130. 130.
    West S, Taylor HR (1999) Bilamellar tarsal rotation is the preferred treatment for trachomatous trichiasis. Surv Ophthalmol 43(5):468PubMedGoogle Scholar
  131. 131.
    Cosar CB, Cohen EJ, Rapuano CJ, Maus M, Penne R, Flanagan JC, Laibson P (2001) Tarsorrhaphy: clinical experience from a cornea practice. Cornea 20(8):787–791PubMedCrossRefGoogle Scholar
  132. 132.
    Balent A (1976) An accidental tarsorrhaphy caused by acrylic adhesive. Am J Ophthalmol 82:501PubMedGoogle Scholar
  133. 133.
    Kirkness CM, Adams GG, Dilliy PN, Lee JP (1988) Botulinum toxin A-induced protective ptosis in corneal disease. Ophthalmology 95(4):473–480PubMedGoogle Scholar
  134. 134.
    Stamler JF, Tse DT (1990) A simple and reliable technique for permanent lateral tarsorrhaphy. Arch Ophthalmol 108:125–127PubMedGoogle Scholar
  135. 135.
    Anderson RL, Gordy DD (1979) The tarsal strip procedure. Arch Ophthalmol 97:2192–2196PubMedGoogle Scholar
  136. 136.
    Kemp EG, Collins JRO (1986) Surgical management of upper eyelid entropion. Br J Ophthalmol 70:575–579PubMedCrossRefGoogle Scholar
  137. 137.
    Ti SE, Tow SL, Chee SP (2000) Amniotic membrane transplantation in entropion surgery. Ophthalmology 108:1209–1217CrossRefGoogle Scholar
  138. 138.
    Putterman AM (1980) Combined z-plasty and horizontal shortening procedure for ectropion. Am J Ophthalmol 89:525–530PubMedGoogle Scholar
  139. 139.
    Vastine DW, Stewart WB, Schwab IR (1982) Reconstruction of the periocular mucous membrane by autologous conjunctival transplantation. Ophthalmology 89:1072–1081PubMedGoogle Scholar
  140. 140.
    Hill JC (1995) Systemic cyclosporin in high-risk keratoplasty: long term results. Eye 9:422–428PubMedGoogle Scholar
  141. 141.
    Virender S, Merle F, Aashish B, Geeta V, Gullapalli R (2005) Early results of penetrating keratoplasty following limbal stem cell transplantation. Indian J Ophthalmol 53(1):31–35CrossRefGoogle Scholar
  142. 142.
    Sanwan VS, Matalia HP, Vemuganti GK, Ifthekar G, Fatima A, Singh S, Rao GN (2005) Early results of penetrating keratoplasty after cultivated limbal epithelium transplantation. Arch Ophthalmol 123:334–340CrossRefGoogle Scholar
  143. 143.
    Daya SM, Ilari FA (2001) Living related conjunctival limbal allograft for the treatment of stem cell deficiency. Ophthalmology 108:126–133PubMedCrossRefGoogle Scholar
  144. 144.
    Ghoraishi M, Akova YA, Tugal-Tutkun I, Foster CS (1995) Penetrating keratoplasty in atopic keratoconjunctivitis. Cornea 14(6):610–613PubMedCrossRefGoogle Scholar
  145. 145.
    Lyons CJ, Dart JKG, Aclimandos WA, Lightman S, Buckley RJ (1990) Scleroscleritis following keratoplasty in atopy. Ophthalmology 97(6):729–733PubMedGoogle Scholar
  146. 146.
    Samson CM, Nduaguba C, Baltatzis S, Foster CS (2002) Limbal stem cell transplantation in chronic inflammatory eye disease. Ophthalmology 109(5):862–868PubMedCrossRefGoogle Scholar
  147. 147.
    Petroutsos G, Drosos A, Pslias K (1992) Repeated melting of corneal grafts in a patient with rheumatoid arthritis and Sjogren’s syndrome. Europ J Ophthalmol 2:36–38Google Scholar
  148. 148.
    Anderson NJ, Hardten DR, McCarty TM (2003) Penetrating keratoplasty and keratolimbal allograft transplantation for corneal perforations associated with the ectodermal dysplasia syndrome. Cornea 22(4):385–388PubMedCrossRefGoogle Scholar
  149. 149.
    Tsubota K, Satake Y, Kaido M, Shinozaki N, Shimmura S, Bissen-Miyajima H, Shimazaki J (1999) Treatment of severe ocular surface disorders with corneal epithelial stem cell transplantation. N Engl J Med 340(22):1697–1703PubMedCrossRefGoogle Scholar
  150. 150.
    Holland EJ, Djalilian AR, Schwartz GS (2003) Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique. Ophthalmology 110(1):125–130PubMedCrossRefGoogle Scholar
  151. 151.
    Dua HS, Azuara-Blanco A (2000) Autologous limbal transplantation in patients with unilateral corneal stem cell deficiency. Br J Ophthalmol 84:273–278PubMedCrossRefGoogle Scholar
  152. 152.
    Kenyon KR, Tseng SCG (1989) Limbal autograft transplantation for ocular surface disorders. Ophthalmology 96(5):709–723PubMedGoogle Scholar
  153. 153.
    Tan DTH, Ficker LA, Buckley RJ (1996) Ophthalmology 103(1):29–36PubMedGoogle Scholar
  154. 154.
    Reinhard T, Sundmacher R, Spelsberg H, Althaus C (1999) Homologous penetrating central limbo-keratoplasty (HPCLK) in bilateral limbal stem cell insufficiency. Acta Ophthalmol Scand 77:663–667PubMedCrossRefGoogle Scholar
  155. 155.
    Solomon A, Ellies P, Anderson DF, Touhami A, Grueterich M, Espana EM, Ti S-E, Goto E, Feuer WJ, Tseng SCG (2002) Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology 109(6):1159–1166PubMedCrossRefGoogle Scholar
  156. 156.
    Lambiase A, Rama P, Bonni S, Caprioglio C, Aloe L (1998) Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Eng J Med 338(17):1174–1177CrossRefGoogle Scholar
  157. 157.
    Nishida T, Nakamura M, Ofuji K, Reid TW, Mannis MJ, Murphy CJ (1996) Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea. J Cell Physiol 169(1):159–166PubMedCrossRefGoogle Scholar
  158. 158.
    Bonini S, Lambiase A, Rama P, Caprioglio G, Aloe L (2000) Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology 107(7):1347–1352PubMedCrossRefGoogle Scholar
  159. 159.
    Lugo M, Arentsen JJ (1987) Treatment of neurotrophic ulcers with conjunctival flaps. Am J Ophthalmol 103:711–712PubMedGoogle Scholar
  160. 160.
    Chen HJ, Pires RT, Tseng SCG (2000) Amniotic membrane transplantation for severe neurotrophic corneal ulcers. Br J Ophthalmol 84:826–833PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2007

Authors and Affiliations

  1. 1.Department of OphthalmologyKing Khaled Eye Specialist HospitalRiyadhKingdom of Saudi Arabia

Personalised recommendations